Jerome Ritz

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Anatomy

Physiology

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Patel Niraj C; Chinen Javier; Rosenblatt Howard M; Hanson I Celine; Krance Robert A; Paul Mary E; Abramson Stuart L; Noroski Lenora M; Davis Carla M; Seeborg Filiz O; Foster Samuel B; Leung Kathryn S; Brown Betty S; Ritz Jerome; Shearer William T
Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning.
Koreth John; Stevenson Kristen E; Kim Haesook T; Garcia Michael; Ho Vincent T; Armand Philippe; Cutler Corey; Ritz Jerome; Antin Joseph H; Soiffer Robert J; Alyea Edwin P
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors.
Ho Vincent T; Vanneman Matthew; Kim Haesook; Sasada Tetsuro; Kang Yoon Joong; Pasek Mildred; Cutler Corey; Koreth John; Alyea Edwin; Sarantopoulos Stefanie; Antin Joseph H; Ritz Jerome; Canning Christine; Kutok Jeffery; Mihm Martin C; Dranoff Glenn; Soiffer Robert
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jerome Ritz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Patel Niraj C; Chinen Javier; Rosenblatt Howard M; Hanson I Celine; Krance Robert A; Paul Mary E; Abramson Stuart L; Noroski Lenora M; Davis Carla M; Seeborg Filiz O; Foster Samuel B; Leung Kathryn S; Brown Betty S; Ritz Jerome; Shearer William T
Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning.
The Journal of allergy and clinical immunology 2009;124(5):1062-9.e1-4.
2009: Koreth John; Stevenson Kristen E; Kim Haesook T; Garcia Michael; Ho Vincent T; Armand Philippe; Cutler Corey; Ritz Jerome; Antin Joseph H; Soiffer Robert J; Alyea Edwin P
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors.
Blood 2009;114(18):3956-9.
2009: Ho Vincent T; Vanneman Matthew; Kim Haesook; Sasada Tetsuro; Kang Yoon Joong; Pasek Mildred; Cutler Corey; Koreth John; Alyea Edwin; Sarantopoulos Stefanie; Antin Joseph H; Ritz Jerome; Canning Christine; Kutok Jeffery; Mihm Martin C; Dranoff Glenn; Soiffer Robert
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(37):15825-30.
2009: Chen Yi-Bin; Kim Haesook T; McDonough Sean; Odze Robert D; Yao Xiaopan; Lazo-Kallanian Suzan; Spitzer Thomas R; Soiffer Robert; Antin Joseph H; Ritz Jerome
Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1066-76.
2009: Sarantopoulos Stefanie; Stevenson Kristen E; Kim Haesook T; Cutler Corey S; Bhuiya Nazmim S; Schowalter Michael; Ho Vincent T; Alyea Edwin P; Koreth John; Blazar Bruce R; Soiffer Robert J; Antin Joseph H; Ritz Jerome
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
Blood 2009;113(16):3865-74.
2009: Zorn Emmanuel; Mohseni Mehrdad; Kim Haesook; Porcheray Fabrice; Lynch Allison; Bellucci Roberto; Canning Christine; Alyea Edwin P; Soiffer Robert J; Ritz Jerome
Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(3):382-8.
2009: Fonseca Catia; Soiffer Robert; Ho Vincent; Vanneman Matthew; Jinushi Masahisa; Ritz Jerome; Neuberg Donna; Stone Richard; DeAngelo Dan; Dranoff Glenn
Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction.
Blood 2009;113(8):1681-8.
2008: Armistead Paul M; Mohseni Mehrdad; Gerwin Roslyn; Walsh Emily C; Iravani Masoud; Chahardouli Bahram; Rostami Shahrbano; Zhang Wandi; Neuberg Donna; Rioux John; Ghavamzadeh Ardeshir; Ritz Jerome; Antin Joseph H; Wu Catherine J
Erythroid-lineage-specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation.
Experimental hematology 2008;36(9):1205-15.
2008: Steigman Shaun A; Armant Myriam; Bayer-Zwirello Lucy; Kao Grace S; Silberstein Leslie; Ritz Jerome; Fauza Dario O
Preclinical regulatory validation of a 3-stage amniotic mesenchymal stem cell manufacturing protocol.
Journal of pediatric surgery 2008;43(6):1164-9.
2008: Jinushi Masahisa; Vanneman Matthew; Munshi Nikhil C; Tai Yu-Tzu; Prabhala Rao H; Ritz Jerome; Neuberg Donna; Anderson Kenneth C; Carrasco Daniel Ruben; Dranoff Glenn
MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(4):1285-90.
2008: Armand Philippe; Kim Haesook T; Cutler Corey S; Ho Vincent T; Koreth John; Ritz Jerome; Alyea Edwin P; Antin Joseph H; Soiffer Robert J
A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1):28-35.
2007: Wu Catherine J; Gladwin Mark; Tisdale John; Hsieh Matthew; Law Terence; Biernacki Melinda; Rogers Shelby; Wang Xunde; Walters Mark; Zahrieh David; Antin Joseph H; Ritz Jerome; Krishnamurti Lakshamanan
Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis.
British journal of haematology 2007;139(3):504-7.
2007: Sarantopoulos Stefanie; Stevenson Kristen E; Kim Haesook T; Bhuiya Nazmim S; Cutler Corey S; Soiffer Robert J; Antin Joseph H; Ritz Jerome
High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6107-14.
2007: Armand Philippe; Kim Haesook T; DeAngelo Daniel J; Ho Vincent T; Cutler Corey S; Stone Richard M; Ritz Jerome; Alyea Edwin P; Antin Joseph H; Soiffer Robert J
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(6):655-64.
2007: Chiaretti Sabina; Tavolaro Simona; Ghia Emanuela Maria; Ariola Cristina; Matteucci Caterina; Elia Loredana; Maggio Roberta; Messina Monica; Ricciardi Maria Rosaria; Vitale Antonella; Ritz Jerome; Mecucci Cristina; Guarini Anna; Foà Robin
Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis.
Haematologica 2007;92(5):619-26.
2007: Bellucci Roberto; Oertelt Sabine; Gallagher Meagan; Li Sigui; Zorn Emmanuel; Weller Edie; Porcheray Fabrice; Alyea Edwin P; Soiffer Robert J; Munshi Nikhil C; Gershwin M Eric; Ritz Jerome
Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis.
Blood 2007;109(5):2001-7.
2007: Mullally Ann; Ritz Jerome
Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation.
Blood 2007;109(4):1355-62.
2006: Brown Jennifer R; Kim Haesook T; Li Shuli; Stephans Katherine; Fisher David C; Cutler Corey; Ho Vincent; Lee Stephanie J; Milford Edgar L; Ritz Jerome; Antin Joseph H; Soiffer Robert J; Gribben John G; Alyea Edwin P
Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(10):1056-64.
2006: Alyea Edwin P; Kim Haesook T; Ho Vincent; Cutler Corey; DeAngelo Daniel J; Stone Richard; Ritz Jerome; Antin Joseph H; Soiffer Robert J
Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(10):1047-55.
2006: Ma Yupo; Cui Wei; Yang Jianchang; Qu Jun; Di Chunhui; Amin Hesham M; Lai Raymond; Ritz Jerome; Krause Diane S; Chai Li
SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice.
Blood 2006;108(8):2726-35.
2006: Zorn Emmanuel; Ritz Jerome
Studying human regulatory T cells in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5265-7.
2006: Zorn Emmanuel; Nelson Erik A; Mohseni Mehrdad; Porcheray Fabrice; Kim Haesook; Litsa Despina; Bellucci Roberto; Raderschall Elke; Canning Christine; Soiffer Robert J; Frank David A; Ritz Jerome
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.
Blood 2006;108(5):1571-9.
2006: Cutler Corey; Miklos David; Kim Haesook T; Treister Nathaniel; Woo Sook-Bin; Bienfang Don; Klickstein Lloyd B; Levin Jesse; Miller Katherine; Reynolds Carol; Macdonell Rebecca; Pasek Mildred; Lee Stephanie J; Ho Vincent; Soiffer Robert; Antin Joseph H; Ritz Jerome; Alyea Edwin
Rituximab for steroid-refractory chronic graft-versus-host disease.
Blood 2006;108(2):756-62.
2006: Chiaretti Sabina; Guarini Anna; De Propris Maria Stefania; Tavolaro Simona; Intoppa Stefania; Vitale Antonella; Iacobelli Simona; Elia Loredana; Ariola Cristina; Ritz Jerome; Foà Robin
ZAP-70 expression in acute lymphoblastic leukemia: association with the E2A/PBX1 rearrangement and the pre-B stage of differentiation and prognostic implications.
Blood 2006;107(1):197-204.
2006: Zubair A C; Kao G; Daley H; Schott D; Freedman A; Ritz J
CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation.
Cytotherapy 2006;8(4):399-407.
2006: Wu Catherine J; Ritz Jerome
Induction of tumor immunity following allogeneic stem cell transplantation.
Advances in immunology 2006;90():133-73.
2005: Gribben John G; Zahrieh David; Stephans Katherine; Bartlett-Pandite Lini; Alyea Edwin P; Fisher David C; Freedman Arnold S; Mauch Peter; Schlossman Robert; Sequist Lecia V; Soiffer Robert J; Marshall Blossom; Neuberg Donna; Ritz Jerome; Nadler Lee M
Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia.
Blood 2005;106(13):4389-96.
2005: Wu Catherine J; Krishnamurti Lakshamanan; Kutok Jeffery L; Biernacki Melinda; Rogers Shelby; Zhang Wandi; Antin Joseph H; Ritz Jerome
Evidence for ineffective erythropoiesis in severe sickle cell disease.
Blood 2005;106(10):3639-45.
2005: Chiaretti Sabina; Li Xiaochun; Gentleman Robert; Vitale Antonella; Wang Kathy S; Mandelli Franco; Foà Robin; Ritz Jerome
Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(20):7209-19.
2005: Zorn Emmanuel; Kim Haesook T; Lee Stephanie J; Floyd Blair H; Litsa Despina; Arumugarajah Sankari; Bellucci Roberto; Alyea Edwin P; Antin Joseph H; Soiffer Robert J; Ritz Jerome
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.
Blood 2005;106(8):2903-11.
2005: Robertson M J; Schacterle R S; Mackin G A; Wilson S N; Bloomingdale K L; Ritz J; Komaroff A L
Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.
Clinical and experimental immunology 2005;141(2):326-32.
2005: Torelli Giovanni F; Guarini Anna; Porzia Alessandra; Chiaretti Sabina; Tatarelli Caterina; Diverio Daniela; Maggio Roberta; Vitale Antonella; Ritz Jerome; Foa Robin
FLT3 inhibition in t(4;11)+ adult acute lymphoid leukaemia.
British journal of haematology 2005;130(1):43-50.
2005: Chiaretti Sabina; Ritz Jerome; Foa Robin
Genomic analysis in lymphoid leukemias.
Reviews in clinical and experimental hematology 2005;9(1):E3.
2005: Tadesse Mahlet G; Ibrahim Joseph G; Gentleman Robert; Chiaretti Sabina; Ritz Jerome; Foa Robin
Bayesian error-in-variable survival model for the analysis of GeneChip arrays.
Biometrics 2005;61(2):488-97.
2005: Wu Catherine J; Biernacki Melinda; Kutok Jeffery L; Rogers Shelby; Chen Linyun; Yang Xiao-Feng; Soiffer Robert J; Ritz Jerome
Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(12):4504-11.
2005: Bellucci Roberto; Alyea Edwin P; Chiaretti Sabina; Wu Catherine J; Zorn Emmanuel; Weller Edie; Wu Bingyan; Canning Christine; Schlossman Robert; Munshi Nikhil C; Anderson Kenneth C; Ritz Jerome
Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor.
Blood 2005;105(10):3945-50.
2005: Miklos David B; Kim Haesook T; Miller Katherine H; Guo Luxuan; Zorn Emmanuel; Lee Stephanie J; Hochberg Ephraim P; Wu Catherine J; Alyea Edwin P; Cutler Corey; Ho Vincent; Soiffer Robert J; Antin Joseph H; Ritz Jerome
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.
Blood 2005;105(7):2973-8.
2005: Alyea Edwin P; Kim Haesook T; Ho Vincent; Cutler Corey; Gribben John; DeAngelo Daniel J; Lee Stephanie J; Windawi Sarah; Ritz Jerome; Stone Richard M; Antin Joseph H; Soiffer Robert J
Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.
Blood 2005;105(4):1810-4.
2005: Ritz Jerome
Immune reconstitution after allogeneic stem cell transplantation.
Haematologica 2005;90(1):5.
2004: DeAngelo Daniel J; Hochberg Ephraim P; Alyea Edwin P; Longtine Janina; Lee Stephanie; Galinsky Ilene; Parekkedon Ben; Ritz Jerome; Antin Joseph H; Stone Richard M; Soiffer Robert J
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5065-71.
2004: Ho Vincent T; Zahrieh David; Hochberg Ephraim; Micale Eileen; Levin Jesse; Reynolds Carol; Steckel Steve; Cutler Corey; Fisher David C; Lee Stephanie J; Alyea Edwin P; Ritz Jerome; Soiffer Robert J; Antin Joseph H
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Blood 2004;104(4):1224-6.
2004: Zorn Emmanuel; Miklos David B; Floyd Blair H; Mattes-Ritz Alex; Guo Luxuan; Soiffer Robert J; Antin Joseph H; Ritz Jerome
Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation.
The Journal of experimental medicine 2004;199(8):1133-42.
2004: Chiaretti Sabina; Li Xiaochun; Gentleman Robert; Vitale Antonella; Vignetti Marco; Mandelli Franco; Ritz Jerome; Foa Robin
Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival.
Blood 2004;103(7):2771-8.
2004: Zubair Abba C; Zahrieh David; Daley Heather; Schott Darlys; Gribben John G; Alyea Edwin P; Schlossman Robert; Freedman Arnold; Antin Joseph H; Soiffer Robert J; Neuberg Donna; Ritz Jerome
Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy.
Transfusion 2004;44(2):253-61.
2004: DeAngelo Daniel J; Ritz Jerome
Imatinib therapy for patients with chronic myelogenous leukemia: are patients living longer?
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):1-3.
2004: Yan Yan; Phan Leuyen; Yang Fan; Talpaz Moshe; Yang Yu; Xiong Zeyu; Ng Bernard; Timchenko Nikolai A; Wu Catherine J; Ritz Jerome; Wang Hong; Yang Xiao-Feng
A novel mechanism of alternative promoter and splicing regulates the epitope generation of tumor antigen CML66-L.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(1):651-60.
2004: Bellucci Roberto; Wu Catherine J; Chiaretti Sabina; Weller Edie; Davies Faith E; Alyea Edwin P; Dranoff Glenn; Anderson Kenneth C; Munshi Nikhil C; Ritz Jerome
Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens.
Blood 2004;103(2):656-63.
2004: Miklos David B; Kim Haesook T; Zorn Emmanuel; Hochberg Ephraim P; Guo Luxuan; Mattes-Ritz Alex; Viatte Sebastien; Soiffer Robert J; Antin Joseph H; Ritz Jerome
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.
Blood 2004;103(1):353-9.
2003: Alyea E; Weller E; Schlossman R; Canning C; Mauch P; Ng A; Fisher D; Gribben J; Freeman A; Parikh B; Richardson P; Soiffer R; Ritz J; Anderson K C
Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect.
Bone marrow transplantation 2003;32(12):1145-51.
2003: Wu Catherine J; Hochberg Ephraim P; Rogers Shelby A; Kutok Jeffery L; Biernacki Melinda; Nascimento Alessandra F; Marks Peter; Bridges Kenneth; Ritz Jerome
Molecular assessment of erythroid lineage chimerism following nonmyeloablative allogeneic stem cell transplantation.
Experimental hematology 2003;31(10):924-33.
2003: Orsini Enrica; Bellucci Roberto; Alyea Edwin P; Schlossman Robert; Canning Christine; McLaughlin Stephen; Ghia Paolo; Anderson Kenneth C; Ritz Jerome
Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusion.
Cancer research 2003;63(10):2561-8.
2003: Zubair Abba; Zahrieh David; Daley Heather; Schott Daryls; Gribben John G; Freedman Arnold; Ritz Jerome
Early neutrophil engraftment following autologous BMT provides a functional predictor of long-term hematopoietic reconstitution.
Transfusion 2003;43(5):614-21.
2003: Hochberg Ephraim P; Miklos David B; Neuberg Donna; Eichner Daniel A; McLaughlin Stephen F; Mattes-Ritz Alex; Alyea Edwin P; Antin Joseph H; Soiffer Robert J; Ritz Jerome
A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation.
Blood 2003;101(1):363-9.
2002: Wu Catherine J; Neuberg Donna; Chillemi Antoinette; McLaughlin Stephen; Hochberg Ephraim P; Galinsky Ilene; DeAngelo Daniel; Soiffer Robert J; Alyea Edwin P; Capdeville Renaud; Stone Richard M; Ritz Jerome
Quantitative monitoring of BCR/ABL transcript during STI-571 therapy.
Leukemia & lymphoma 2002;43(12):2281-9.
2002: Yang Xiao-Feng; Wu Catherine J; Chen Linyun; Alyea Edwin P; Canning Christine; Kantoff Philip; Soiffer Robert J; Dranoff Glenn; Ritz Jerome
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
Cancer research 2002;62(19):5517-22.
2002: Bellucci Roberto; Ritz Jerome
Allogeneic stem cell transplantation for multiple myeloma.
Reviews in clinical and experimental hematology 2002;6(3):205-24.
2002: Zubair Abba C; Silberstein Leslie; Ritz Jerome
Adult hematopoietic stem cell plasticity.
Transfusion 2002;42(8):1096-101.
2002: Zorn Emmanuel; Wang Kathy S; Hochberg Ephraim P; Canning Christine; Alyea Edwin P; Soiffer Robert J; Ritz Jerome
Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2052-60.
2002: Friedberg Jonathan W; Neuberg Donna; Gribben John G; Fisher David C; Canning Christine; Koval Margaret; Poor Christine M; Green Luke M; Daley John; Soiffer Robert; Ritz Jerome; Freedman Arnold S
Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphoma.
British journal of haematology 2002;117(4):828-34.
2002: Testa Ugo; Torelli Giovanni F; Riccioni Roberta; Muta Andrea Onetti; Militi Stefania; Annino Luciana; Mariani Gualtiero; Guarini Anna; Chiaretti Sabina; Ritz Jerome; Mandelli Franco; Peschle Cesare; Foa Robin
Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors.
Blood 2002;99(12):4634-7.
2002: Bellucci Roberto; Alyea Edwin P; Weller Edie; Chillemi Antoinette; Hochberg Ephraim; Wu Catherine J; Canning Christine; Schlossman Robert; Soiffer Robert J; Anderson Kenneth C; Ritz Jerome
Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma.
Blood 2002;99(12):4610-7.
2002: Hodi F Stephen; Schmollinger Jan C; Soiffer Robert J; Salgia Ravi; Lynch Thomas; Ritz Jerome; Alyea Edwin P; Yang Jihong; Neuberg Donna; Mihm Martin; Dranoff Glenn
ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(10):6919-24.
2002: Zaki Mohamed H; Wysocka Maria; Everetts Suzanne E; Wang Kathy S; French Lars E; Ritz Jerome; Rook Alain H
Synergistic enhancement of cell-mediated immunity by interleukin-12 plus interleukin-2: basis for therapy of cutaneous T cell lymphoma.
The Journal of investigative dermatology 2002;118(2):366-71.
2002: Soiffer Robert J; Alyea Edwin P; Hochberg Ephraim; Wu Catherine; Canning Christine; Parikh Bijal; Zahrieh David; Webb Iain; Antin Joseph; Ritz Jerome
Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(11):625-32.
2002: Alyea E; Neuberg D; Mauch P; Marcus K; Freedman A; Webb I; Anderson K; Schlossman R; Fisher D; Gribben J; Ritz J; Soiffer R
Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(3):139-44.
2001: Hochberg E P; Chillemi A C; Wu C J; Neuberg D; Canning C; Hartman K; Alyea E P; Soiffer R J; Kalams S A; Ritz J
Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults.
Blood 2001;98(4):1116-21.
2001: Alyea E; Weller E; Schlossman R; Canning C; Webb I; Doss D; Mauch P; Marcus K; Fisher D; Freeman A; Parikh B; Gribben J; Soiffer R; Ritz J; Anderson K
T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect.
Blood 2001;98(4):934-9.
2001: Yang X F; Wu C J; McLaughlin S; Chillemi A; Wang K S; Canning C; Alyea E P; Kantoff P; Soiffer R J; Dranoff G; Ritz J
CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(13):7492-7.
2001: Wang K S; Zorn E; Ritz J
Specific down-regulation of interleukin-12 signaling through induction of phospho-STAT4 protein degradation.
Blood 2001;97(12):3860-6.
2001: Zorn E; Orsini E; Wu C J; Stein B; Chillemi A; Canning C; Alyea E P; Soiffer R J; Ritz J
A CD4+ T cell clone selected from a CML patient after donor lymphocyte infusion recognizes BCR-ABL breakpoint peptides but not tumor cells.
Transplantation 2001;71(8):1131-7.
2001: Soiffer R J; Weller E; Alyea E P; Mauch P; Webb I L; Fisher D C; Freedman A S; Schlossman R L; Gribben J; Lee S; Anderson K C; Marcus K; Stone R M; Antin J H; Ritz J
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1152-9.
2001: Mahajan S; Gollob J A; Ritz J; Frank D A
CD2 stimulation leads to the delayed and prolonged activation of STAT1 in T cells but not NK cells.
Experimental hematology 2001;29(2):209-20.
2000: Wu C J; Yang X F; McLaughlin S; Neuberg D; Canning C; Stein B; Alyea E P; Soiffer R J; Dranoff G; Ritz J
Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia.
The Journal of clinical investigation 2000;106(5):705-14.
2000: Wang K S; Frank D A; Ritz J
Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4.
Blood 2000;95(10):3183-90.
2000: Orsini E; Alyea E P; Schlossman R; Canning C; Soiffer R J; Chillemi A; Neuberg D; Anderson K C; Ritz J
Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion.
Bone marrow transplantation 2000;25(6):623-32.
2000: Wu C J; Chillemi A; Alyea E P; Orsini E; Neuberg D; Soiffer R J; Ritz J
Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism.
Blood 2000;95(1):352-9.
2000: Orsini E; Alyea E P; Chillemi A; Schlossman R; McLaughlin S; Canning C; Soiffer R J; Anderson K C; Ritz J
Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(4):375-86.
1999: Freedman A S; Neuberg D; Mauch P; Soiffer R J; Anderson K C; Fisher D C; Schlossman R; Alyea E P; Takvorian T; Jallow H; Kuhlman C; Ritz J; Nadler L M; Gribben J G
Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.
Blood 1999;94(10):3325-33.
1999: Friedberg J W; Neuberg D; Stone R M; Alyea E; Jallow H; LaCasce A; Mauch P M; Gribben J G; Ritz J; Nadler L M; Soiffer R J; Freedman A S
Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3128-35.
1999: Borrego F; Robertson M J; Ritz J; Peña J; Solana R
CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor.
Immunology 1999;97(1):159-65.
1999: Frank D A; Mahajan S; Ritz J
Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling.
Nature medicine 1999;5(4):444-7.
1999: Gollob J A; Schnipper C P; Murphy E A; Ritz J; Frank D A
The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(8):4472-81.
1999: Sehn L H; Alyea E P; Weller E; Canning C; Lee S; Ritz J; Antin J H; Soiffer R J
Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):561-8.
1999: Dahia P L; Aguiar R C; Alberta J; Kum J B; Caron S; Sill H; Marsh D J; Ritz J; Freedman A; Stiles C; Eng C
PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies.
Human molecular genetics 1999;8(2):185-93.
1999: Robertson M J; Cameron C; Atkins M B; Gordon M S; Lotze M T; Sherman M L; Ritz J
Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(1):9-16.
1999: Wang K S; Ritz J; Frank D A
IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(1):299-304.
1999: Friedberg J W; Neuberg D; Gribben J G; Mauch P; Anderson K C; Soiffer R J; Takvorian T; Fisher D C; Schlossman R; Jallow H; Kuhlman C; Ritz J; Freedman A S
Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(4):262-8.
1998: Lee S J; Weller E; Alyea E P; Ritz J; Soiffer R J
Efficacy and costs of granulocyte colony-stimulating factor in allogeneic T-cell depleted bone marrow transplantation.
Blood 1998;92(8):2725-9.
1998: David D; Bani L; Moreau J L; Treilhou M P; Demaison C; Sun K; Février M; Salvucci O; Cayota A; Nakarai T; Chouaïb S; de Montalembert M; Joussemet M; Sugamura K; Ritz J; Dupont B; Pialoux G; Thèze J
Dysregulation of interleukin-2 receptor beta and interleukin-2 receptor gamma expression during HIV infection.
European cytokine network 1998;9(3 Suppl):97-101.
1998: David D; Bani L; Moreau J L; Treilhou M P; Nakarai T; Joussemet M; Ritz J; Dupont B; Pialoux G; Thèze J
Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(19):11348-53.
1998: Gollob J A; Schnipper C P; Orsini E; Murphy E; Daley J F; Lazo S B; Frank D A; Neuberg D; Ritz J
Characterization of a novel subset of CD8(+) T cells that expands in patients receiving interleukin-12.
The Journal of clinical investigation 1998;102(3):561-75.
1998: Delabesse E; Bernard M; Meyer V; Smit L; Pulford K; Cayuela J M; Ritz J; Bourquelot P; Strominger J L; Valensi F; Macintyre E A
TAL1 expression does not occur in the majority of T-ALL blasts.
British journal of haematology 1998;102(2):449-57.
1998: Soiffer R J; Freedman A S; Neuberg D; Fisher D C; Alyea E P; Gribben J; Schlossman R L; Bartlett-Pandite L; Kuhlman C; Murray C; Freeman A; Mauch P; Anderson K C; Nadler L M; Ritz J
CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
Bone marrow transplantation 1998;21(12):1177-81.
1998: Barzegar C; Meazza R; Pereno R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boyé D; Doucet C; Taoufik Y; Ritz J; Musselli C; Mishal Z; Jasmin C; Indiveri F; Ferrini S; Azzarone B
IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops.
Oncogene 1998;16(19):2503-12.
1998: Alyea E P; Soiffer R J; Canning C; Neuberg D; Schlossman R; Pickett C; Collins H; Wang Y; Anderson K C; Ritz J
Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant.
Blood 1998;91(10):3671-80.
1998: Voss S D; Daley J; Ritz J; Robertson M J
Participation of the CD94 receptor complex in costimulation of human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(4):1618-26.
1998: Gollob J A; Murphy E A; Mahajan S; Schnipper C P; Ritz J; Frank D A
Altered interleukin-12 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1.
Blood 1998;91(4):1341-54.
1998: Freedman A S; Neuberg D; Gribben J G; Mauch P; Soiffer R J; Fisher D C; Anderson K C; Andersen N; Schlossman R; Kroon M; Ritz J; Aster J; Nadler L M
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):13-8.
1998: David D; Bani L; Moreau J L; Demaison C; Sun K; Salvucci O; Nakarai T; de Montalembert M; Chouaïb S; Joussemet M; Ritz J; Thèze J
Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets.
Blood 1998;91(1):165-72.
1997: Frank D A; Mahajan S; Ritz J
B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.
The Journal of clinical investigation 1997;100(12):3140-8.
1997: Freedman A; Neuberg D; Mauch P; Gribben J; Soiffer R; Anderson K; Robertson M; Fisher D C; Schlossman R; Kroon M; Rhuda C; Kuhlman C; Ritz J; Nadler L
Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulating factor markedly depletes stem cell reserve for autologous bone marrow transplantation.
Blood 1997;90(12):4996-5001.
1997: Webb I J; Soiffer R J; Andersen J W; Cohen C A; Freeman A; Sugrue M; Ritz J; Anderson K C
In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(5):267-72.
1997: Sato T; Ohashi Y; Tachibana K; Soiffer R J; Ritz J; Morimoto C
Altered tyrosine phosphorylation via the very late antigen (VLA)/beta1 integrin stimulation is associated with impaired T-cell signaling through VLA-4 after allogeneic bone marrow transplantation.
Blood 1997;90(10):4222-9.
1997: Weisdorf D J; Billett A L; Hannan P; Ritz J; Sallan S E; Steinbuch M; Ramsay N K
Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia.
Blood 1997;90(8):2962-8.
1997: Kolenko V; Wang Q; Riedy M C; O'Shea J; Ritz J; Cathcart M K; Rayman P; Tubbs R; Edinger M; Novick A; Bukowski R; Finke J
Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):3057-67.
1997: Ida H; Robertson M J; Voss S; Ritz J; Anderson P
CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(5):2154-60.
1997: Claret E J; Alyea E P; Orsini E; Pickett C C; Collins H; Wang Y; Neuberg D; Soiffer R J; Ritz J
Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion.
The Journal of clinical investigation 1997;100(4):855-66.
1997: Wang D; Freeman G J; Levine H; Ritz J; Robertson M J
Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
British journal of haematology 1997;97(2):409-17.
1997: Soiffer R J; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(1):11-7.
1997: Bani L; David D; Moreau J L; Cayota A; Nakarai T; Ritz J; Thèze J
Expression of the IL-2 receptor gamma subunit in resting human CD4 T lymphocytes: mRNA is constitutively transcribed and the protein stored as an intracellular component.
International immunology 1997;9(4):573-80.
1997: Soiffer R J; Fairclough D; Robertson M; Alyea E; Anderson K; Freedman A; Bartlett-Pandite L; Fisher D; Schlossman R L; Stone R; Murray C; Freeman A; Marcus K; Mauch P; Nadler L; Ritz J
CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.
Blood 1997;89(8):3039-47.
1997: Atkins M B; Robertson M J; Gordon M; Lotze M T; DeCoste M; DuBois J S; Ritz J; Sandler A B; Edington H D; Garzone P D; Mier J W; Canning C M; Battiato L; Tahara H; Sherman M L
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(3):409-17.
1997: Gollob J A; Kawasaki H; Ritz J
Interferon-gamma and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high-affinity interleukin-12 receptor expression.
European journal of immunology 1997;27(3):647-52.
1997: Lynch T J; Lambert J M; Coral F; Shefner J; Wen P; Blattler W A; Collinson A R; Ariniello P D; Braman G; Cook S; Esseltine D; Elias A; Skarin A; Ritz J
Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):723-34.
1997: Soiffer R J; Chapman P B; Murray C; Williams L; Unger P; Collins H; Houghton A N; Ritz J
Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(1):17-24.
1996: McLean T W; Ringold S; Neuberg D; Stegmaier K; Tantravahi R; Ritz J; Koeffler H P; Takeuchi S; Janssen J W; Seriu T; Bartram C R; Sallan S E; Gilliland D G; Golub T R
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.
Blood 1996;88(11):4252-8.
1996: Vance E A; Soiffer R J; McDonald G B; Myerson D; Fingeroth J; Ritz J
Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon.
Transplantation 1996;62(9):1358-60.
1996: Gollob J A; Ritz J
CD2-CD58 interaction and the control of T-cell interleukin-12 responsiveness. Adhesion molecules link innate and acquired immunity.
Annals of the New York Academy of Sciences 1996;795():71-81.
1996: Freedman A S; Gribben J G; Neuberg D; Mauch P; Soiffer R J; Anderson K C; Pandite L; Robertson M J; Kroon M; Ritz J; Nadler L M
High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission.
Blood 1996;88(7):2780-6.
1996: Webb I J; Coral F S; Andersen J W; Elias A D; Finberg R W; Nadler L M; Ritz J; Anderson K C
Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.
Transfusion 1996;36(9):782-8.
1996: Pignata C; Sanghera J S; Soiffer R J; Chartier S; Eder M; Pelech S L; Ritz J
Defective activation of mitogen-activated protein kinase after allogeneic bone marrow transplantation.
Blood 1996;88(6):2334-41.
1996: Provan D; Bartlett-Pandite L; Zwicky C; Neuberg D; Maddocks A; Corradini P; Soiffer R; Ritz J; Nadler L M; Gribben J G
Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation.
Blood 1996;88(6):2228-35.
1996: Boussiotis V A; Pardo N A; Collins H; Houghton A; Ritz J; Nadler L M; Soiffer R J
R24 anti-GD3 ganglioside antibody can induce costimulation and prevent the induction of alloantigen-specific T cell clonal anergy.
European journal of immunology 1996;26(9):2149-54.
1996: Gollob J A; Li J; Kawasaki H; Daley J F; Groves C; Reinherz E L; Ritz J
Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(5):1886-93.
1996: Ernst M; Stein H; Ludwig D; Boese-Landgraf J; Ritz J; Häring R
Surgical therapy of gastrointestinal non-Hodgkin's lymphomas.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1996;22(2):177-81.
1996: Soiffer R J; Murray C; Shapiro C; Collins H; Chartier S; Lazo S; Ritz J
Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin 2.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(3):493-9.
1996: Taplin M E; Frantz M E; Canning C; Ritz J; Blumberg R S; Balk S P
Evidence against T-cell development in the adult human intestinal mucosa based upon lack of terminal deoxynucleotidyltransferase expression.
Immunology 1996;87(3):402-7.
1996: Nguyen P L; Harris N L; Ritz J; Robertson M J
Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
The American journal of pathology 1996;148(3):847-53.
1996: Schumann R R; Nakarai T; Gruss H J; Brach M A; von Arnim U; Kirschning C; Karawajew L; Ludwig W D; Renauld J C; Ritz J; Herrmann F
Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells.
Blood 1996;87(6):2419-27.
1996: Robertson M J; Cochran K J; Cameron C; Le J M; Tantravahi R; Ritz J
Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
Experimental hematology 1996;24(3):406-15.
1996: Robertson M J; Cameron C; Lazo S; Cochran K J; Voss S D; Ritz J
Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
Natural immunity 1996;15(5):213-26.
1995: Pignata C; Prasad K V; Hallek M; Druker B; Rudd C E; Robertson M J; Ritz J
Phosphorylation of src family lck tyrosine kinase following interleukin-12 activation of human natural killer cells.
Cellular immunology 1995;165(2):211-6.
1995: Gollob J A; Li J; Reinherz E L; Ritz J
CD2 regulates responsiveness of activated T cells to interleukin 12.
The Journal of experimental medicine 1995;182(3):721-31.
1995: Frank D A; Robertson M J; Bonni A; Ritz J; Greenberg M E
Interleukin 2 signaling involves the phosphorylation of Stat proteins.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(17):7779-83.
1995: Seiden M V; Schlossman R; Andersen J; Freeman A; Robertson M; Soiffer R; Freedman A; Mauch P; Ritz J; Nadler L
Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma.
Leukemia & lymphoma 1995;17(1-2):87-93.
1995: Robertson M J; Manley T J; Pichert G; Cameron C; Cochran K J; Levine H; Ritz J
Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Leukemia & lymphoma 1995;17(1-2):51-61.
1995: Soiffer R J; Murray C; Ritz J; Phillips N; Jacobsohn D; Chartier S; Ambrosino D M
Recombinant interleukin-2 infusions and decreased IgG2 subclass concentrations.
Blood 1995;85(4):925-8.
1995: Kameoka J; Sato T; Torimoto Y; Sugita K; Soiffer R J; Schlossman S F; Ritz J; Morimoto C
Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation.
Blood 1995;85(4):1132-7.
1995: Lew M A; Kehoe K; Ritz J; Antman K H; Nadler L; Kalish L A; Finberg R
Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):239-50.
1995: Roy D C; Perreault C; Bélanger R; Gyger M; Le Houillier C; Blättler W A; Lambert J M; Ritz J
Elimination of B-lineage leukemia and lymphoma cells from bone marrow grafts using anti-B4-blocked-ricin immunotoxin.
Journal of clinical immunology 1995;15(1):51-7.
1995: Soiffer R J; Alyea E P; Ritz J
Immunomodulatory effects of donor lymphocyte infusions following allogeneic bone marrow transplantation.
Journal of clinical apheresis 1995;10(3):139-43.
1994: Boussiotis V A; Barber D L; Nakarai T; Freeman G J; Gribben J G; Bernstein G M; D'Andrea A D; Ritz J; Nadler L M
Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor.
Science (New York, N.Y.) 1994;266(5187):1039-42.
1994: Pichert G; Alyea E P; Soiffer R J; Roy D C; Ritz J
Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Blood 1994;84(7):2109-14.
1994: Burke P A; Canning C M; Chartier S; Lazo S; Daley J; Forse R A; Ritz J
Alterations in Ca2+ signal transduction in critically ill surgical patients.
Surgery 1994;116(2):378-86; discussion 386-7.
1994: Soiffer R J; Murray C; Gonin R; Ritz J
Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation.
Blood 1994;84(3):964-71.
1994: Sugita K; Nojima Y; Tachibana K; Soiffer R J; Murray C; Schlossman S F; Ritz J; Morimoto C
Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation.
The Journal of clinical investigation 1994;94(2):481-8.
1994: Nakarai T; Robertson M J; Streuli M; Wu Z; Ciardelli T L; Smith K A; Ritz J
Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells.
The Journal of experimental medicine 1994;180(1):241-51.
1994: Sugita K; Soiffer R J; Murray C; Schlossman S F; Ritz J; Morimoto C
The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation.
Transplantation 1994;57(10):1465-73.
1994: Klumpp T R; Fairclough D; Ritz J; Soiffer R
The effect of minor ABO mismatches on the incidence of graft-versus-host disease after allogeneic bone marrow transplantation.
Transplantation 1994;57(5):780.
1994: Schlossman S F; Boumsell L; Gilks W; Harlan J M; Kishimoto T; Morimoto C; Ritz J; Shaw S; Silverstein R L; Springer T A
CD antigens 1993.
Immunology today 1994;15(3):98-9.
1994: Ritz J
Tumor immunity: will new keys unlock the door?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):237-8.
1994: Schlossman S F; Boumsell L; Gilks W; Harlan J M; Kishimoto T; Morimoto C; Ritz J; Shaw S; Silverstein R L; Springer T A
CD antigens 1993.
Blood 1994;83(4):879-80.
1994: McIntyre G D; Scott C F; Ritz J; Blättler W A; Lambert J M
Preparation and characterization of interleukin-2-gelonin conjugates made using different cross-linking reagents.
Bioconjugate chemistry 1994;5(1):88-97.
1994: Pignata C; Sanghera J S; Cossette L; Pelech S L; Ritz J
Interleukin-12 induces tyrosine phosphorylation and activation of 44-kD mitogen-activated protein kinase in human T cells.
Blood 1994;83(1):184-90.
1994: Schlossman S F; Boumsell L; Gilks W; Harlan J M; Kishimoto T; Morimoto C; Ritz J; Shaw S; Silverstein R L; Springer T A
CD antigens 1993.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(1):1-2.
1994: Robertson M J; Ritz J
Prognostic significance of the surface antigens expressed by leukemic cells.
Leukemia & lymphoma 1994;13 Suppl 1():15-22.
1994: Robertson M J; Roy D C; Stone R M; Ritz J
Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia.
Progress in clinical and biological research 1994;389():47-63.
1994: Epstein C; Lynch T; Shefner J; Wen P; Maxted D; Braman V; Ariniello P; Coral F; Ritz J
Use of the immunotoxin N901-blocked ricin in patients with small-cell lung cancer.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1994;8():57-9.
1993: Pignata C; Prasad K V; Robertson M J; Levine H; Rudd C E; Ritz J
Fc gamma RIIIA-mediated signaling involves src-family lck in human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(12):6794-800.
1993: Soiffer R J; Robertson M J; Murray C; Cochran K; Ritz J
Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies.
Blood 1993;82(9):2790-6.
1993: Pichert G; Ritz J
Clinical significance of bcr-abl gene rearrangement detected by the polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.
Leukemia & lymphoma 1993;10(1-2):1-8.
1993: Billett A L; Kornmehl E; Tarbell N J; Weinstein H J; Gelber R D; Ritz J; Sallan S E
Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia.
Blood 1993;81(6):1651-7.
1993: Robertson M J; Manley T J; Donahue C; Levine H; Ritz J
Costimulatory signals are required for optimal proliferation of human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(5):1705-14.
1993: Soiffer R J; Ritz J
Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results.
Bone marrow transplantation 1993;12 Suppl 3():S7-10.
1992: Macintyre E A; Smit L; Ritz J; Kirsch I R; Strominger J L
Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor alpha beta lineage.
Blood 1992;80(6):1511-20.
1992: Sugita K; Robertson M J; Torimoto Y; Ritz J; Schlossman S F; Morimoto C
Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(4):1199-203.
1992: Klumpp T R; Block C C; Caligiuri M A; Rabinowe S N; Soiffer R J; Ritz J
Immune-mediated cytopenia following bone marrow transplantation. Case reports and review of the literature.
Medicine 1992;71(2):73-83.
1992: Robertson M J; Soiffer R J; Wolf S F; Manley T J; Donahue C; Young D; Herrmann S H; Ritz J
Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.
The Journal of experimental medicine 1992;175(3):779-88.
1992: Grossbard M L; Freedman A S; Ritz J; Coral F; Goldmacher V S; Eliseo L; Spector N; Dear K; Lambert J M; Blättler W A
Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion.
Blood 1992;79(3):576-85.
1992: Soiffer R J; Murray C; Cochran K; Cameron C; Wang E; Schow P W; Daley J F; Ritz J
Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation.
Blood 1992;79(2):517-26.
1992: Baume D M; Robertson M J; Levine H; Manley T J; Schow P W; Ritz J
Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
European journal of immunology 1992;22(1):1-6.
1992: Tycko B; Ritz J; Sallan S; Sklar J
Changing antigen receptor gene rearrangements in a case of early pre-B cell leukemia: evidence for a tumor progenitor cell with stem cell features and implications for monitoring residual disease.
Blood 1992;79(2):481-8.
1991: Soiffer R J; Dear K; Rabinowe S N; Anderson K C; Freedman A S; Murray C; Tarbell N J; Mauch P; Nadler L M; Ritz J
Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation.
Transplantation 1991;52(6):1014-9.
1991: Delage R; Soiffer R J; Dear K; Ritz J
Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.
Blood 1991;78(10):2759-67.
1991: Robertson M J; Socinski M A; Soiffer R J; Finberg R W; Wilson C; Anderson K C; Bosserman L; Sang D N; Salkin I F; Ritz J
Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemia.
Bone marrow transplantation 1991;8(2):143-5.
1991: Freedman A S; Ritz J; Neuberg D; Anderson K C; Rabinowe S N; Mauch P; Takvorian T; Soiffer R; Blake K; Yeap B
Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma.
Blood 1991;77(11):2524-9.
1991: Roy D C; Griffin J D; Belvin M; Blättler W A; Lambert J M; Ritz J
Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of acute myeloid leukemia cells.
Blood 1991;77(11):2404-12.
1991: Blomquist M D; Boggards M; Hanson I C; Rosenblatt H M; Pollack M S; Hawkins E; Ritz J; Shearer W T
Monoclonal anti-T cell (T12) antibody treatment of graft-versus-host disease in severe combined immunodeficiency: targeting of antibody and activation of complement on CD8+ cytotoxic T cell surfaces.
The Journal of allergy and clinical immunology 1991;87(5):1029-33.
1991: Lew M A; Kehoe K; Ritz J; Antman K H; Nadler L; Takvorian T; Mayer R; Kalish L; Finberg R
Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation.
Transplantation 1991;51(3):630-6.
1991: Anderson K C; Barut B A; Ritz J; Freedman A S; Takvorian T; Rabinowe S N; Soiffer R; Heflin L; Coral F; Dear K
Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma.
Blood 1991;77(4):712-20.
1990: Robertson M J; Ritz J
Biology and clinical relevance of human natural killer cells.
Blood 1990;76(12):2421-38.
1990: Baume D M; Caligiuri M A; Manley T J; Daley J F; Ritz J
Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells.
Cellular immunology 1990;131(2):352-65.
1990: Klumpp T R; Caligiuri M A; Rabinowe S N; Soiffer R J; Murray C; Ritz J;
Autoimmune pancytopenia following allogeneic bone marrow transplantation.
Bone marrow transplantation 1990;6(6):445-7.
1990: Jochelson M; Tarbell N J; Freedman A S; Rabinowe S N; Takvorian T; Soiffer R; Anderson K; Ritz J; Nadler L M
Acute and chronic pulmonary complications following autologous bone marrow transplantation in non-Hodgkin's lymphoma.
Bone marrow transplantation 1990;6(5):329-31.
1990: Robertson M J; Caligiuri M A; Manley T J; Levine H; Ritz J
Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(10):3194-201.
1990: Soiffer R J; Bosserman L; Murray C; Cochran K; Daley J; Ritz J
Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation.
Blood 1990;75(10):2076-84.
1990: Caligiuri M A; Zmuidzinas A; Manley T J; Levine H; Smith K A; Ritz J
Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors.
The Journal of experimental medicine 1990;171(5):1509-26.
1990: Delage R; Ritz J; Anderson K C
The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemia.
Hematology/oncology clinics of North America 1990;4(2):369-88.
1990: Anderson P; Caligiuri M; O'Brien C; Manley T; Ritz J; Schlossman S F
Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(6):2274-8.
1990: Roy D C; Tantravahi R; Murray C; Dear K; Gorgone B; Anderson K C; Freedman A S; Nadler L M; Ritz J
Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium.
Blood 1990;75(1):296-304.
1990: Roy D C; Felix M; Cannady W G; Cannistra S; Ritz J
Comparative activities of rabbit complements of different ages using an in-vitro marrow purging model.
Leukemia research 1990;14(5):407-16.
1989: Pedrazzini A; Freedman A S; Andersen J; Heflin L; Anderson K; Takvorian T; Canellos G P; Whitman J; Coral F; Ritz J
Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function.
Blood 1989;74(6):2203-11.
1989: Young L; Alfieri C; Hennessy K; Evans H; O'Hara C; Anderson K C; Ritz J; Shapiro R S; Rickinson A; Kieff E
Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.
The New England journal of medicine 1989;321(16):1080-5.
1989: Anderson P; Caligiuri M; Ritz J; Schlossman S F
CD3-negative natural killer cells express zeta TCR as part of a novel molecular complex.
Nature 1989;341(6238):159-62.
1989: Caligiuri M A; Murray C; Levine H; Longtine J A; Ritz J
Clonal evidence for the induction of NKH1 on activated human thymocytes. Functional changes associated with antigen expression.
European journal of immunology 1989;19(9):1735-9.
1989: Scott C F; Bolender S; McIntyre G D; Holldack J; Lambert J M; Venkatesh Y P; Morimoto C; Ritz J; Schlossman S F
Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(11):4105-12.
1989: Ritz J
The role of natural killer cells in immune surveillance.
The New England journal of medicine 1989;320(26):1748-9.
1989: Bosserman L D; Murray C; Takvorian T; Anderson K C; Freedman A S; Fitzsimmons J; Coral F; Nadler L M; Schlossman S F; Ritz J
Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients.
Bone marrow transplantation 1989;4(3):239-45.
1989: Kamada M M; Michon J; Ritz J; Holldack J; Serafin W E; Austen K F; MacDermott R P; Stevens R L
Identification of carboxypeptidase and tryptic esterase activities that are complexed to proteoglycans in the secretory granules of human cloned natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(2):609-15.
1989: Anderson K C; Barut B A; Ritz J; Freedman A S; Nadler L M
Autologous bone marrow transplantation therapy for multiple myeloma.
European journal of haematology. Supplementum 1989;51():157-63.
1988: Ernst T J; Gazdar A; Ritz J; Shipp M A
Identification of a second transforming gene, rasn, in a human multiple myeloma line with a rearranged c-myc allele.
Blood 1988;72(4):1163-7.
1988: Shipp M A; Richardson N E; Sayre P H; Brown N R; Masteller E L; Clayton L K; Ritz J; Reinherz E L
Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(13):4819-23.
1988: Hafler D A; Ritz J; Schlossman S F; Weiner H L
Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(1):131-8.
1988: Michon J M; Caligiuri M A; Hazanow S M; Levine H; Schlossman S F; Ritz J
Induction of natural killer effectors from human thymus with recombinant IL-2.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(10):3660-7.
1988: Schmidt R E; Caulfield J P; Michon J; Hein A; Kamada M M; MacDermott R P; Stevens R L; Ritz J
T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(3):991-1002.
1988: Ritz J; Schmidt R E; Michon J; Hercend T; Schlossman S F
Characterization of functional surface structures on human natural killer cells.
Advances in immunology 1988;42():181-211.
1988: Freedman A S; Takvorian T; Nadler L M; Anderson K C; Sallan S E; Ritz J
Autologous bone marrow transplantation in acute leukemia and lymphoma following ex vivo treatment with monoclonal antibodies and complement.
Cancer treatment and research 1988;38():265-83.
1987: Li F P; Gimbrere K; Ritz J; Saito H; Longtine J A
Lymphoma with clonal T-cell receptor gene rearrangement in a 25-year survivor of Hodgkin's disease.
Cancer 1987;60(9):2213-8.
1987: Caligiuri M; Murray C; Buchwald D; Levine H; Cheney P; Peterson D; Komaroff A L; Ritz J
Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(10):3306-13.
1987: Takvorian T; Canellos G P; Ritz J; Freedman A S; Anderson K C; Mauch P; Tarbell N; Coral F; Daley H; Yeap B
Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.
The New England journal of medicine 1987;316(24):1499-505.
1987: Hokland P; Hokland M; Daley J; Ritz J
Identification and cloning of a prethymic precursor T lymphocyte from a population of common acute lymphoblastic leukemia antigen (CALLA)-positive fetal bone marrow cells.
The Journal of experimental medicine 1987;165(6):1749-54.
1987: Caulfield J P; Hein A; Schmidt R E; Ritz J
Ultrastructural evidence that the granules of human natural killer cell clones store membrane in a nonbilayer phase.
The American journal of pathology 1987;127(2):305-16.
1987: Rosenblatt H M; Lewis D E; Sklar J; Cleary M L; Parikh N; Galili N; Ritz J; Shearer W T
Epstein-Barr virus-transformed B-cell line (DV-1) derived from bone marrow of a patient with severe combined immunodeficiency and immunoblastic lymphoma.
Pediatric research 1987;21(4):331-7.
1987: Anderson K C; Ritz J; Takvorian T; Coral F; Daley H; Gorgone B C; Freedman A S; Canellos G P; Schlossman S F; Nadler L M
Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow.
Blood 1987;69(2):597-604.
1987: Schmidt R E; Michon J M; Woronicz J; Schlossman S F; Reinherz E L; Ritz J
Enhancement of natural killer function through activation of the T11 E rosette receptor.
The Journal of clinical investigation 1987;79(1):305-8.
1987: Herrmann F; Schmidt R E; Ritz J; Griffin J D
In vitro regulation of human hematopoiesis by natural killer cells: analysis at a clonal level.
Blood 1987;69(1):246-54.
1987: Anderson K C; Nadler L M; Takvorian T; Freedman A S; Canellos G P; Schlossman S F; Ritz J
Monoclonal antibodies: their use in bone marrow transplantation.
Progress in hematology 1987;15():137-81.
1987: Niemeyer C M; Ritz J; Donahue K; Sallan S E
Monoclonal-antibody-purged autologous bone marrow transplantation for relapsed non-T-cell acute lymphoblastic leukemia in childhood.
Haematology and blood transfusion 1987;31():67-74.
1987: Schmidt R E; Schlossman S F; Reinherz E L; Ritz J
Activation of natural killer function through the T11/E rosette receptor.
Haematology and blood transfusion 1987;31():347-50.
1986: Tedder T F; Schmidt R E; Rudd C E; Kornacki M M; Ritz J; Schlossman S F
Function of the LFA-1 and T4 molecules in the direct activation of resting human B lymphocytes by T lymphocytes.
European journal of immunology 1986;16(12):1539-43.
1986: Delmon L; Ythier A; Moingeon P; Nowill A; Bayle C; Pico J L; Hayat M; Ritz J; Hercend T
Characterization of antileukemia cells' cytotoxic effector function. Implications for monitoring natural killer responses following allogeneic bone marrow transplantation.
Transplantation 1986;42(3):252-6.
1986: Letvin N L; Chalifoux L V; Reimann K A; Ritz J; Schlossman S F; Lambert J M
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. Delivery of ribosome-inactivating proteins to spleen and lymph node T cells.
The Journal of clinical investigation 1986;78(3):666-73.
1986: Knowlton R G; Brown V A; Braman J C; Barker D; Schumm J W; Murray C; Takvorian T; Ritz J; Donis-Keller H
Use of highly polymorphic DNA probes for genotypic analysis following bone marrow transplantation.
Blood 1986;68(2):378-85.
1986: Rohatiner A; Gelber R; Schlossman S F; Ritz J
Depletion of T cells from human bone marrow using monoclonal antibodies and rabbit complement. A quantitative and functional analysis.
Transplantation 1986;42(1):73-80.
1986: Schmidt R E; Murray C; Daley J F; Schlossman S F; Ritz J
A subset of natural killer cells in peripheral blood displays a mature T cell phenotype.
The Journal of experimental medicine 1986;164(1):351-6.
1986: Milanese C; Siliciano R F; Schmidt R E; Ritz J; Richardson N E; Reinherz E L
A lymphokine that activates the cytolytic program of both cytotoxic T lymphocyte and natural killer clones.
The Journal of experimental medicine 1986;163(6):1583-8.
1986: Schmidt R E; Bartley G T; Lee S S; Daley J F; Royer H D; Levine H; Reinherz E L; Schlossman S F; Ritz J
Expression of the NKTa clonotype in a series of human natural killer clones with identical cytotoxic specificity.
The Journal of experimental medicine 1986;163(4):812-25.
1986: Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast R C
Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Cancer research 1986;46(3):1208-13.
1986: Letvin N L; Goldmacher V S; Ritz J; Yetz J M; Schlossman S F; Lambert J M
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates.
The Journal of clinical investigation 1986;77(3):977-84.
1986: Hercend T; Takvorian T; Nowill A; Tantravahi R; Moingeon P; Anderson K C; Murray C; Bohuon C; Ythier A; Ritz J
Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation.
Blood 1986;67(3):722-8.
1986: Goldmacher V S; Lambert J M; Young A Y; Anderson J; Tinnel N L; Kornacki M; Ritz J; Blättler W A
Expression of the common acute lymphoblastic leukemia antigen (CALLA) on the surface of individual cells of human lymphoblastoid lines.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(1):320-5.
1986: De Fabritiis P; Bregni M; Lipton J; Reynolds C; Nadler L; Ritz J; Bast R C
Antigenic heterogeneity among Burkitt's lymphoma cells surviving treatment with monoclonal antibody and complement.
Leukemia research 1986;10(1):35-42.
1985: MacDermott R P; Schmidt R E; Caulfield J P; Hein A; Bartley G T; Ritz J; Schlossman S F; Austen K F; Stevens R L
Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis.
The Journal of experimental medicine 1985;162(6):1771-87.
1985: Schmidt R E; Hercend T; Schlossman S F; Ritz J
Functional surface structures on human natural killer cells.
Klinische Wochenschrift 1985;63(23):1189-200.
1985: Schmidt R E; MacDermott R P; Bartley G; Bertovich M; Amato D A; Austen K F; Schlossman S F; Stevens R L; Ritz J
Specific release of proteoglycans from human natural killer cells during target lysis.
Nature 1985;318(6043):289-91.
1985: Letvin N L; Ritz J; Guida L J; Yetz J M; Lambert J M; Reinherz E L; Schlossman S F
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates: I. Effects of anti-T11 antibodies on the circulating T cell pool.
Blood 1985;66(4):961-6.
1985: Siliciano R F; Pratt J C; Schmidt R E; Ritz J; Reinherz E L
Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein.
Nature 1985;317(6036):428-30.
1985: Hokland P; Ritz J; Schlossman S F; Nadler L M
Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(3):1746-51.
1985: Takahashi M; Ritz J; Cooper G M
Activation of a novel human transforming gene, ret, by DNA rearrangement.
Cell 1985;42(2):581-8.
1985: Schmidt R E; Bartley G; Levine H; Schlossman S F; Ritz J
Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(2):1020-5.
1985: Schmidt R E; Hercend T; Fox D A; Bensussan A; Bartley G; Daley J F; Schlossman S F; Reinherz E L; Ritz J
The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(1):672-8.
1985: Ritz J; Campen T J; Schmidt R E; Royer H D; Hercend T; Hussey R E; Reinherz E L
Analysis of T-cell receptor gene rearrangement and expression in human natural killer clones.
Science (New York, N.Y.) 1985;228(4707):1540-3.
1985: De Fabritiis P; Bregni M; Lipton J; Greenberger J; Nadler L; Rothstein L; Korbling M; Ritz J; Bast R C
Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement.
Blood 1985;65(5):1064-70.
1985: Shearer W T; Ritz J; Finegold M J; Guerra I C; Rosenblatt H M; Lewis D E; Pollack M S; Taber L H; Sumaya C V; Grumet F C
Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency.
The New England journal of medicine 1985;312(18):1151-9.
1985: Hercend T; Griffin J D; Bensussan A; Schmidt R E; Edson M A; Brennan A; Murray C; Daley J F; Schlossman S F; Ritz J
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.
The Journal of clinical investigation 1985;75(3):932-43.
1985: Greenberger J S; Rothstein L; DeFabritiis P; Bregni M; Bast R; Ritz J; Nadler L M; Lipton J M; Sakakeeny M A
Effects of monoclonal antibody and complement treatment of human marrow on hematopoiesis in continuous bone marrow culture.
Cancer research 1985;45(2):758-67.
1985: Bast R C; De Fabritiis P; Lipton J; Gelber R; Maver C; Nadler L; Sallan S; Ritz J
Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
Cancer research 1985;45(2):499-503.
1984: Hercend T; Schmidt R; Brennan A; Edson M A; Reinherz E L; Schlossman S F; Ritz J
Identification of a 140-kDa activation antigen as a target structure for a series of human cloned natural killer cell lines.
European journal of immunology 1984;14(9):844-52.
1984: Hokland P; Nadler L M; Griffin J D; Schlossman S F; Ritz J
Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow.
Blood 1984;64(3):662-6.
1984: Hercend T; Meuer S; Brennan A; Edson M A; Acuto O; Reinherz E L; Schlossman S F; Ritz J
Natural killer-like function of activated T lymphocytes: differential blocking effects of monoclonal antibodies specific for a 90-kDa clonotypic structure.
Cellular immunology 1984;86(2):381-92.
1984: Ritz J; Bast R C; Takvorian T; Sallan S E
Clinical applications of monoclonal antibodies in acute leukemia.
Annals of the New York Academy of Sciences 1984;428():308-17.
1983: Hercend T; Meuer S; Brennan A; Edson M A; Acuto O; Reinherz E L; Schlossman S F; Ritz J
Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function.
The Journal of experimental medicine 1983;158(5):1547-60.
1983: Ritz J
Use of monoclonal antibodies in autologous and allogeneic bone marrow transplantation.
Clinics in haematology 1983;12(3):813-32.
1983: Diamond A; Cooper G M; Ritz J; Lane M A
Identification and molecular cloning of the human Blym transforming gene activated in Burkitt's lymphomas.
Nature 1983;305(5930):112-6.
1983: Griffin J D; Ritz J; Beveridge R P; Lipton J M; Daley J F; Schlossman S F
Expression of MY7 antigen on myeloid precursor cells.
International journal of cell cloning 1983;1(1):33-48.
1983: Greaves M F; Hariri G; Newman R A; Sutherland D R; Ritter M A; Ritz J
Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts.
Blood 1983;61(4):628-39.
1983: Pegoraro L; Matera L; Ritz J; Levis A; Palumbo A; Biagini G
Establishment of a Ph1-positive human cell line (BV173).
Journal of the National Cancer Institute 1983;70(3):447-53.
1983: Bast R C; Ritz J; Lipton J M; Feeney M; Sallan S E; Nathan D G; Schlossman S F
Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
Cancer research 1983;43(3):1389-94.
1983: Hercend T; Reinherz E L; Meuer S; Schlossman S F; Ritz J
Phenotypic and functional heterogeneity of human cloned natural killer cell lines.
Nature 1983;301(5896):158-60.
1983: Hokland P; Rosenthal P; Griffin J D; Nadler L M; Daley J; Hokland M; Schlossman S F; Ritz J
Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA).
The Journal of experimental medicine 1983;157(1):114-29.
1983: Griffin J D; Todd R F; Ritz J; Nadler L M; Canellos G P; Rosenthal D; Gallivan M; Beveridge R P; Weinstein H; Karp D; Schlossman S F
Differentiation patterns in the blastic phase of chronic myeloid leukemia.
Blood 1983;61(1):85-91.
1983: Hokland M; Ritz J; Hokland P
Interferon-induced changes in expression of antigens defined by monoclonal antibodies on malignant and nonmalignant mononuclear hematopoietic cells.
Journal of interferon research 1983;3(2):199-210.
1983: Ritz J; Sallan S E; Bast R C; Lipton J M; Nathan D G; Schlossman S F
In vitro treatment with monoclonal antibody prior to autologous bone marrow transplantation in acute lymphoblastic leukemia.
Haematology and blood transfusion 1983;28():117-23.
1982: Hercend T; Meuer S; Reinherz E L; Schlossman S F; Ritz J
Generation of a cloned NK cell line derived from the "null cell" fraction of human peripheral blood.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(3):1299-305.
1982: Nadler L M; Ritz J; Bates M P; Park E K; Anderson K C; Sallan S E; Schlossman S F
Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia.
The Journal of clinical investigation 1982;70(2):433-42.
1982: Ritz J; Sallan S E; Bast R C; Lipton J M; Clavell L A; Feeney M; Hercend T; Nathan D G; Schlossman S F
Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement.
Lancet 1982;2(8289):60-3.
1982: Rosenberg J M; Kirschenbaum H L; Saleem G; Ritz J; Martino F P
Benoxaprofen and cyproheptadine.
The Journal of the Medical Society of New Jersey 1982;79(5):413-4.
1982: Raso V; Ritz J; Basala M; Schlossman S F
Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Cancer research 1982;42(2):457-64.
1982: Ritz J; Schlossman S F
Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma.
Blood 1982;59(1):1-11.
1981: Ritz J; Pesando J M; Notis-McConarty J; Clavell L A; Sallan S E; Schlossman S F
Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia.
Cancer research 1981;41(11 Pt 2):4771-5.
1981: Hercend T; Ritz J; Schlossman S F; Reinherz E L
Comparative expression of T9, T10, and Ia antigens on activated human T cell subsets.
Human immunology 1981;3(3):247-59.
1981: Griffin J D; Ritz J; Nadler L M; Schlossman S F
Expression of myeloid differentiation antigens on normal and malignant myeloid cells.
The Journal of clinical investigation 1981;68(4):932-41.
1981: Hercend T; Nadler L M; Pesando J M; Reinherz E L; Schlossman S F; Ritz J
Expression of a 26,000-dalton glycoprotein on activated human T cells.
Cellular immunology 1981;64(1):192-9.
1981: Ritz J; Nadler L M; Bhan A K; Notis-McConarty J; Pesando J M; Schlossman S F
Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage.
Blood 1981;58(3):648-52.
1981: Pesando J M; Nadler L M; Lazarus H; Tomaselli K J; Stashenko P; Ritz J; Levine H; Yunis E J; Schlossman S F
Human cell lines express multiple populations of Ia-like molecules.
Human immunology 1981;3(1):67-76.
1981: Clavell L A; Lipton J M; Bast R C; Kudisch M; Pesando J; Scholssman S F; Ritz J
Absence of common ALL antigen on normal bipotent myeloid, erythroid, and granulocyte progenitors.
Blood 1981;58(2):333-6.
1981: Ritz J; Pesando J M; Sallan S E; Clavell L A; Notis-McConarty J; Rosenthal P; Schlossman S F
Serotherapy of acute lymphoblastic leukemia with monoclonal antibody.
Blood 1981;58(1):141-52.
1981: Bernard A; Boumsell L; Reinherz E L; Nadler L M; Ritz J; Coppin H; Richard Y; Valensi F; Dausset J; Flandrin G; Lemerle J; Schlossman S F
Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma.
Blood 1981;57(6):1105-10.
1981: Boumsell L; Bernard A; Reinherz E L; Nadler L M; Ritz J; Coppin H; Richard Y; Dubertret L; Valensi F; Degos L; Lemerle J; Flandrin G; Dausset J; Schlossman S F
Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells.
Blood 1981;57(3):526-30.
1981: Pesando J M; Ritz J; Lazarus H; Tomaselli K J; Schlossman S F
Fate of a common acute lymphoblastic leukemia antigen during modulation by monoclonal antibody.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(2):540-4.
1981: Nadler L M; Ritz J; Hardy R; Pesando J M; Schlossman S F; Stashenko P
A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
The Journal of clinical investigation 1981;67(1):134-40.
1981: Nadler L M; Ritz J; Griffin J D; Todd R F; Reinherz E L; Schlossman S F
Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.
Progress in hematology 1981;12():187-225.
1981: Todd R F; Griffin J D; Ritz J; Nadler L M; Abrams T; Schlossman S F
Expression of normal monocyte-macrophage differentiation antigens on HL60 promyelocytes undergoing differentiation induced by leukocyte-conditioned medium or phorbol diester.
Leukemia research 1981;5(6):491-5.
1981: Greaves M F; Robinson J B; Delia D; Ritz J; Schlossman S; Sieff C; Goldstein G; Kung P; Bollum F J; Edwards P A
Comparative antigenic phenotypes of normal and leukemic hemopoietic precursor cells analysed with a "library" of monoclonal antibodies.
Haematology and blood transfusion 1981;26():296-304.
1980: Ritz J; Pesando J M; Notis-McConarty J; Schlossman S F
Modulation of human acute lymphoblastic leukemia antigen induced by monoclonal antibody in vitro.
Journal of immunology (Baltimore, Md. : 1950) 1980;125(4):1506-14.
1980: Pesando J M; Ritz J; Levine H; Terhorst C; Lazarus H; Schlossman S F
Human leukemia-associated antigen: relation to a family of surface glycoproteins.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(6):2794-9.
1980: Sallan S E; Ritz J; Pesando J; Gelber R; O'Brien C; Hitchcock S; Coral F; Schlossman S F
Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia.
Blood 1980;55(3):395-402.
1980: Ritz J; Pesando J M; Notis-McConarty J; Lazarus H; Schlossman S F
A monoclonal antibody to human acute lymphoblastic leukaemia antigen.
Nature 1980;283(5747):583-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jerome Ritz

Research Profile (preview)

Procedures

Chemicals & Drugs

Anatomy

Physiology

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jerome Ritz (preview)

All Publications